Cristy is primarily responsible for identifying life science investment opportunities, performing due diligence, and negotiating and monitoring West Coast portfolio investments.

Cristy joined Lighthouse in February 2002 as a Principal in the Menlo Park, California office. Before joining LCP, Cristy had seven prior years of experience in public and private equity investing, most recently having spent two years as a Senior Associate at Highland Capital Partners. Prior to Highland, Cristy spent five years at Robertson Stephens in the Technology Research Group.

Cristy's area of investment focus is in life sciences, encompassing biotech and medical devices. While at Lighthouse, Cristy has sponsored over 40 investments, including Anacor Pharmaceuticals, ARYx Pharamceuticals (NASDAQ: ARYX), Cameron Health, Direct Flow Medical, Fluidigm, ForteBio, Glaukos Corporation, Hemosense (AMEX: HEM), Intuity Medical, Novalar Pharmaceuticals, Novacardia (Acquired by Merck), Ocera, and Proteus BioMedical. Cristy has also been involved in Bayhill Therapeutics and ParAllele Biosciences (acquired by Affymetrix).

Cristy holds a BA in Psychology with a minor in Business from the University of California, Los Angeles.